ESICM Lives | The role of hemoadsorption in Intensive Care - Key learnings and best practice
Dec 3-5, 2025 | Hamburg, Germany Save the date for our Campfire sessions focusing on direct dialogue and idea sharing (in German)
26. November 2025 | Dokumentation in der Praxis: Fallstricke vermeiden
CytoSorbents & Hemoadsorption
When it comes to critical health challenges, you can rely on us as your trusted partner.
We understand that healthcare professionals need to rely on advanced technologies designed to support high-quality patient care.
CytoSorbents’ adsorption technology is broadening the applications of blood purification, offering a mechanism to support physiological balance and assist in the management of harmful substances – complementary to conventional dialysis approaches.
Our Innovation
The Power of the Bead
Our solutions are based on proprietary, biocompatible, and highly porous polymer bead technology designed to reduce elevated levels of certain potentially harmful compounds from whole blood by hemoadsorption.
-
Our SolutionCytoSorb 300®
Learn more about CytoSorbRestore balance to support clinical management
*Not available in the US
-
Our SolutionPuriFi
Learn more about PuriFiEmpowering independent hemoadsorption therapy
*Not available in the US
-
Our SolutionECOS-300CY
Learn more about ECOSSupporting ex vivo organ perfusion through adsorptive removal of inflammatory mediators
*Not available in the US
-
Our SolutionVetResQ
Learn more about VetResQCytoSorb technology designed for veterinary critical-care applications
*Available only in the US
Use of CytoSorb in therapeutic areas
The CytoSorb adsorber serves as the basis for an extracorporeal blood purification therapy designed to reduce elevated levels of certain potentially harmful compounds from whole blood by hemoadsorption.
Our Team of Experts
Expertise you can count on the moment you need it.
Voices around the world
